Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts
2022 · The Lancet · 145 citations
https://doi.org/10.1016/s0140-6736(22)02079-7
J
Joshua K. Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
1.3K
Citations
17
h-index
19
i10-index
Joshua K. Park is an academic researcher from Physiological Society. The author has contributed to research in topics: Genetic Associations and Epidemiology & Cannabis and Cannabinoid Research & Genomics and Rare Diseases. The author has an h-index of 17, co-authored 36 publications.
ORCID: 0000-0002-1719-3537Papers by this author
worksNetwork analyses identify liver‐specific targets for treating liver diseases
2017 · Molecular Systems Biology · 117 citations
https://doi.org/10.15252/msb.20177703
Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice
2020 · Nature Chemical Biology · 95 citations
https://doi.org/10.1038/s41589-020-0528-7
Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis
2019 · American Journal of Respiratory Cell and Molecular Biology · 26 citations
https://doi.org/10.1165/rcmb.2018-0147oc
Expanding drug targets for 112 chronic diseases using a machine learning-assisted genetic priority score
2024 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-024-53333-y
Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank
2024 · Atherosclerosis · 6 citations
https://doi.org/10.1016/j.atherosclerosis.2024.119103
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat